# Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT

> **NCT04560218** · PHASE3 · COMPLETED · sponsor: **Department of Medical Services Ministry of Public Health of Thailand** · enrollment: 135 (actual)

## Conditions studied

- To Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women

## Interventions

- **DRUG:** sublingual Misoprostol
- **DRUG:** Intrauterine Misoprostol

## Key facts

- **NCT ID:** NCT04560218
- **Lead sponsor:** Department of Medical Services Ministry of Public Health of Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-30
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-09-10
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04560218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04560218, "Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04560218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*